Targeting cGAS-STING: modulating the immune landscape of hepatic diseases
Liver diseases, including viral hepatitis, alcoholic liver disease (ALD), metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatocellular carcinoma (HCC), represent a significant threat to global health due to their high mortality rates. The cGAS-STING pathway, a critical part o...
Saved in:
| Main Authors: | Feng Xue, Yong-Kang Liu, Xiao-Ying Chen, Shan-Shan Chen, Xiang-Rong Yu, Hua-Wen Li, Li-Gong Lu, Mu-He Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1498323/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
cGAS-STING Targeting Offers Novel Therapeutic Opportunities in Liver Diseases
by: Wang Y, et al.
Published: (2025-07-01) -
The cGAS-STING pathway in atherosclerosis
by: Si-yu Wang, et al.
Published: (2025-04-01) -
Correction: The cGAS-STING pathway in atherosclerosis
by: Si-yu Wang, et al.
Published: (2025-06-01) -
Ciprofloxacin Exerts Anti-Tumor Effects In Vivo Through cGAS-STING Activation and Modulates Tumor Microenvironment
by: Jian-Syun Chen, et al.
Published: (2025-07-01) -
Verteporfin inhibits the cGAS-STING pathway and improves the tumor microenvironment during cisplatin treatment in hepatocellular carcinoma
by: Yi Gong, et al.
Published: (2025-08-01)